Female infertility
Ginefiv S.L. focuses on clinical research in reproductive medicine, with particular attention to treatment strategies for female infertility in patients undergoing assisted conception.
- Embryo accumulation for preimplantation genetic testing for aneuploidy (PGT-A)
- Double ovarian stimulation and DUOSTIM approaches
- Ovarian stimulation protocols in fertility care
Its research activity is centered on clinical strategies used in assisted reproductive technology, with interest in optimizing outcomes for patients preparing embryos for genetic assessment.
Ovarian stimulation and pituitary suppression
The sponsor’s clinical work includes comparison of progestin-primed ovarian stimulation (PPOS) and GnRH antagonist approaches within fertility treatment pathways.
- Progestin-based pituitary suppression
- GnRH antagonist protocols
- Controlled ovarian stimulation
These areas reflect a therapeutic interest in hormonal control during stimulation cycles for patients requiring embryo collection.
Embryology and genetic selection
Clinical research activity extends to embryo quality assessment and the generation of euploid embryos for use in fertility treatment planning.
- Euploid embryo yield
- Embryo selection in reproductive care
- Genetic evaluation of embryos
This area connects laboratory-based reproductive assessment with clinical decision-making in patients undergoing PGT-A.
